Mental health among Ebola survivors in Liberia, Sierra Leone and Guinea: results from a cross-sectional study.
epidemiology
mental health
public health
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
26 05 2020
26 05 2020
Historique:
entrez:
29
5
2020
pubmed:
29
5
2020
medline:
15
5
2021
Statut:
epublish
Résumé
To describe the prevalence and correlates of depression and anxiety among adult Ebola virus disease (EVD) survivors in Liberia, Sierra Leone and Guinea. Cross-sectional. One-on-one surveys were conducted in EVD-affected communities in Liberia, Sierra Leone and Guinea in early 2018. 1495 adult EVD survivors (726 male, 769 female). Patient Health Questionnaire-9 (PHQ-9) depression scores and Generalised Anxiety Disorder-7 (GAD-7) scores. Prevalence and severity of depression and anxiety varied across the three countries. Sierra Leone had the highest prevalence of depression, with 22.0% of participants meeting the criteria for a tentative diagnosis of depression, compared with 20.2% in Liberia and 13.0% in Guinea. Sierra Leone also showed the highest prevalence of anxiety, with 10.7% of participants meeting criteria for generalized anxiety disorder (GAD-7 score ≥10), compared with 9.9% in Liberia and 4.2% in Guinea. Between one-third and one-half of respondents reported little interest or pleasure in doing things in the previous 2 weeks (range: 47.0% in Liberia to 37.6% in Sierra Leone), and more than 1 in 10 respondents reported ideation of self-harm or suicide (range: 19.4% in Sierra Leone to 10.4% in Guinea). Higher depression and anxiety scores were statistically significantly associated with each other and with experiences of health facility-based stigma in all three countries. Other associations between mental health scores and respondent characteristics varied across countries. Our results indicate that both depression and anxiety are common among EVD survivors in Liberia, Sierra Leone and Guinea, but that there is country-level heterogeneity in prevalence, severity and correlates of these conditions. All three countries should work to make mental health services available for survivors, and governments and organisations should consider the intersection between EVD-related stigma and mental health when designing programmes and training healthcare providers.
Identifiants
pubmed: 32461296
pii: bmjopen-2019-035217
doi: 10.1136/bmjopen-2019-035217
pmc: PMC7259862
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e035217Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
BMC Psychiatry. 2017 Apr 4;17(1):127
pubmed: 28376850
PLoS One. 2018 Feb 6;13(2):e0191782
pubmed: 29408928
Psychiatry Res. 2013 Dec 15;210(2):653-61
pubmed: 23972787
Front Psychiatry. 2019 Oct 31;10:758
pubmed: 31736794
Front Public Health. 2016 Jul 04;4:142
pubmed: 27458576
BMJ Glob Health. 2016 Nov 18;1(3):e000108
pubmed: 28588963
BMJ Glob Health. 2018 Apr 1;3(2):e000410
pubmed: 29629189
Lancet Infect Dis. 2016 Mar;16(3):331-8
pubmed: 26725449
Lancet Infect Dis. 2017 May;17(5):545-552
pubmed: 28094208
Lancet Infect Dis. 2016 Jun;16(6):e82-e91
pubmed: 27020309
BMC Public Health. 2018 Jul 27;18(1):919
pubmed: 30049270
BMC Health Serv Res. 2017 Jul 27;17(1):508
pubmed: 28750617
Trop Med Int Health. 2019 Jun;24(6):671-691
pubmed: 30843627
Int J Health Policy Manag. 2017 Sep 03;7(5):402-411
pubmed: 29764104
J Affect Disord. 2014;167:160-6
pubmed: 24972364
Int J Ment Health Syst. 2019 Aug 24;13:58
pubmed: 31462908
Glob Health Action. 2014 Nov 07;7:26058
pubmed: 25382685
PLoS One. 2018 Nov 28;13(11):e0206595
pubmed: 30485311
PLoS One. 2015 Feb 06;10(2):e0116820
pubmed: 25658103
N Engl J Med. 2019 Mar 7;380(10):924-934
pubmed: 30855742
MMWR Morb Mortal Wkly Rep. 2017 Oct 20;66(41):1109-1115
pubmed: 29049279
Int J Methods Psychiatr Res. 2014 Dec;23(4):422-38
pubmed: 25048296
AIDS Res Treat. 2018 Feb 28;2018:5462959
pubmed: 29682344
J Affect Disord. 2016 Jul 1;198:50-5
pubmed: 27011359
BMJ Glob Health. 2018 Mar 17;3(2):e000471
pubmed: 29607096
Lancet. 2001 Oct 20;358(9290):1350
pubmed: 11684230
Open Forum Infect Dis. 2018 Sep 21;5(10):ofy239
pubmed: 30386807
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941